InCellDx, Inc. — Form D
InCellDx, Inc. of Hayward, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-23. The offering totals $13.5M, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-07-23
- Form: D
- Accession: 0001494461-24-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $13.5M
- Amount sold: $500K
- Remaining: $13.0M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2024-07-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-519545
Issuer
- Name: InCellDx, Inc.
- CIK: 0001494461
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 30920 Huntwood Avenue, Hayward, CA, 94544
- Phone: 650-777-7630
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Brian Recroft Brothen | Executive Officer | Palm Coast, FL |
| Bruce Patterson | Executive Officer | Frankfort, MI |
| Chris Lawrence Wheeler | Executive Officer | Atherton, CA |
| Bruce Patterson | Director | Frankfort, MI |
| Lowell T Gruman | Executive Officer | Traverse City, MI |
| Charles T Todd | Director | Elmwood Park, NJ |
| Thaddeus T Taube | Director | Belmont, CA |
| Eric Hass | Executive Officer | Menlo Park, CA |
| Marc D Grodman | Director | Elmwood Park, NJ |
| Carol Penfold-Patterson | Director | Menlo Park, CA |
| Carol Penfold-Patterson | Executive Officer | Menlo Park, CA |
| Linda Law | Director | Menlo Park, CA |
Other filings by this issuer (2)
More